Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
4.070
-0.620 (-13.22%)
At close: Jul 31, 2026, 4:00 PM EDT
4.090
+0.020 (0.49%)
After-hours: Jul 31, 2026, 7:59 PM EDT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $1.82 billion as of July 31, 2026. Its market cap has increased by 103.82% in one year.
Market Cap
1.82B
Enterprise Value
1.55B
1-Year Change
103.82%
Ranking
Category
Stock Price
$4.07
ChartMarket Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $1.82B, an increase of 642.95%. That is a compound annual growth rate of 19.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.82B | 67.69% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 1.87B |
| UroGen Pharma | 1.86B |
| Kardigan | 1.86B |
| Fortrea Holdings | 1.82B |
| Lakefront Biotherapeutics NV | 1.81B |
| Stoke Therapeutics | 1.80B |
| Generate Biomedicines | 1.79B |
| Agios Pharmaceuticals | 1.79B |